Literature DB >> 17406983

Class III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cells.

Christos D Katsetos1, Eduarda Dráberová, Barbora Smejkalová, Goutham Reddy, Louise Bertrand, Jean-Pierre de Chadarévian, Agustin Legido, Jonathan Nissanov, Peter W Baas, Pavel Dráber.   

Abstract

We have previously shown that the neuronal-associated class III beta-tubulin isotype and the centrosome-associated gamma-tubulin are aberrantly expressed in astrocytic gliomas (Cell Motil Cytoskeleton 2003, 55:77-96; J Neuropathol Exp Neurol 2006, 65:455-467). Here we determined the expression, distribution and interaction of betaIII-tubulin and gamma-tubulin in diffuse-type astrocytic gliomas (grades II-IV) (n = 17) and the human glioblastoma cell line T98G. By immunohistochemistry and immunofluorescence microscopy, betaIII-tubulin and gamma-tubulin were co-distributed in anaplastic astrocytomas and glioblastomas and to a lesser extent, in low-grade diffuse astrocytomas (P < 0.05). In T98G glioblastoma cells betaIII-tubulin was associated with microtubules whereas gamma-tubulin exhibited striking diffuse cytoplasmic staining in addition to its expectant centrosome-associated pericentriolar distribution. Treatment with different anti-microtubule drugs revealed that betaIII-tubulin was not associated with insoluble gamma-tubulin aggregates. On the other hand, immunoprecipitation experiments unveiled that both tubulins formed complexes in soluble cytoplasmic pools, where substantial amounts of these proteins were located. We suggest that aberrant expression and interactions of betaIII-tubulin and gamma-tubulin may be linked to malignant changes in glial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406983     DOI: 10.1007/s11064-007-9321-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

1.  Monoclonal antibody NF-09 specific for neurofilament protein NF-M.

Authors:  E Dráberová; V Sulimenko; V Kukharskyy; P Dráber
Journal:  Folia Biol (Praha)       Date:  1999       Impact factor: 0.906

2.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Heterogeneity of tubulin epitopes in mouse fetal tissues.

Authors:  P Dráber; L A Lagunowich; E Dráberová; V Viklický; I Damjanov
Journal:  Histochemistry       Date:  1988

4.  Accumulation of 210 kDa microtubule-interacting protein in differentiating P19 embryonal carcinoma cells.

Authors:  M Zíková; V Sulimenko; P Dráber; E Dráberová
Journal:  FEBS Lett       Date:  2000-05-04       Impact factor: 4.124

5.  Immunophenotype of pleomorphic xanthoastrocytoma.

Authors:  Caterina Giannini; Bernd W Scheithauer; Maria B S Lopes; Takanori Hirose; Johan M Kros; Scott R VandenBerg
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

6.  Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.

Authors:  S Ranganathan; C A Benetatos; P J Colarusso; D W Dexter; G R Hudes
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

7.  Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

Authors:  Charles Dumontet; Sylvie Isaac; Pierre-Jean Souquet; Françoise Bejui-Thivolet; Yves Pacheco; Nadine Peloux; Anthony Frankfurter; Richard Luduena; Maurice Perol
Journal:  Bull Cancer       Date:  2005-02       Impact factor: 1.276

8.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

9.  Structural models for the self-assembly and microtubule interactions of gamma-, delta- and epsilon-tubulin.

Authors:  Y F Inclán; E Nogales
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  A microtubule-interacting protein involved in coalignment of vimentin intermediate filaments with microtubules.

Authors:  E Dráberová; P Dráber
Journal:  J Cell Sci       Date:  1993-12       Impact factor: 5.285

View more
  28 in total

1.  Microtubule-severing ATPase spastin in glioblastoma: increased expression in human glioblastoma cell lines and inverse roles in cell motility and proliferation.

Authors:  Eduarda Dráberová; Stanislav Vinopal; Gerardo Morfini; Pei S Liu; Vladimíra Sládková; Tetyana Sulimenko; Matthew R Burns; Joanna Solowska; Kandan Kulandaivel; Jean-Pierre de Chadarévian; Agustin Legido; Sverre J Mörk; Jiří Janáček; Peter W Baas; Pavel Dráber; Christos D Katsetos
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

Review 2.  Molecular alterations in glioblastoma: potential targets for immunotherapy.

Authors:  Azizul Haque; Naren L Banik; Swapan K Ray
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

3.  Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.

Authors:  Yiming Li; Yuchao Liang; Zhiyan Sun; Kaibin Xu; Xing Fan; Shaowu Li; Zhong Zhang; Tao Jiang; Xing Liu; Yinyan Wang
Journal:  Neuroradiology       Date:  2019-06-19       Impact factor: 2.804

4.  A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis.

Authors:  Raphael Berges; Julien Balzeau; Alan C Peterson; Joel Eyer
Journal:  Mol Ther       Date:  2012-04-10       Impact factor: 11.454

Review 5.  Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Authors:  Amandeep Thakur; Chetna Faujdar; Ram Sharma; Sachin Sharma; Basant Malik; Kunal Nepali; Jing Ping Liou
Journal:  J Med Chem       Date:  2022-07-05       Impact factor: 8.039

6.  HSP70 regulates the function of mitotic centrosomes.

Authors:  Chieh-Ting Fang; Hsiao-Hui Kuo; Tiffany S Pan; Fu-Chi Yu; Ling-Huei Yih
Journal:  Cell Mol Life Sci       Date:  2016-04-30       Impact factor: 9.261

Review 7.  Beyond taxol: microtubule-based treatment of disease and injury of the nervous system.

Authors:  Peter W Baas; Fridoon J Ahmad
Journal:  Brain       Date:  2013-06-27       Impact factor: 13.501

Review 8.  Targeting pericytes for angiogenic therapies.

Authors:  Molly R Kelly-Goss; Rick S Sweat; Peter C Stapor; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2014-05       Impact factor: 2.628

9.  End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.

Authors:  Raphael Berges; Nathalie Baeza-Kallee; Emeline Tabouret; Olivier Chinot; Marie Petit; Anna Kruczynski; Dominique Figarella-Branger; Stephane Honore; Diane Braguer
Journal:  Oncotarget       Date:  2014-12-30

10.  Neurotrophic effects of Botulinum neurotoxin type A in hippocampal neurons involve activation of Rac1 by the non-catalytic heavy chain (HCC/A).

Authors:  Luis Solabre Valois; Vanilla Hua Shi; Paul Bishop; Bangfu Zhu; Yasuko Nakamura; Kevin A Wilkinson; Jeremy M Henley
Journal:  IBRO Neurosci Rep       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.